Clinuvel Pharmaceuticals | CUV - 销售和管理费用

股票价格

9.10

每天变化

-0.13 -1.41%

每月一次

-5.80%

每年

-14.07%

Q2 预测

8.91

金融业

AUD

AUD 269.7M

现金及等价物

AUD 35.2M

AUD 2.64M

AUD 261.38M

AUD 17.85M

AUD 879.78K

股息收益率

0.57

AUD 13.51M

AUD 27.55M

16

EPS每股收益

AUD 0.21

股本和储备

AUD 249.02M

AUD 57.82M

债务利息支出

AUD 2.49M

AUD 17.25K

AUD 462.06M

AUD 10.44M

AUD 23.42M

AUD 13.51M

普通股股本

AUD 50.2M

19.34

AUD 28.8M

AUD 36.93M

销售和管理费用

AUD 3.85M

AUD 9.52M

贸易债权人

AUD 10.68M

应收帐款人

AUD 16.58M

	销售和管理费用	更改		日
Avita Medical	AUD 19.03M		1.95M	2025-12
Medical Developments International	AUD 2.84M		4.19M	2025-12
Mesoblast	USD 28.54M		9.69M	2025-12
Neuren Pharmaceuticals	AUD 3.74M		2.5M	2025-12
Pacific Edge	NZD 19.17M		1.32M	2025-12
Paradigm Biopharmaceuticals	AUD 2.83M		1.22M	2025-12
PYC Therapeutics	AUD 328.4K		1.8M	2025-12
Telix Pharmaceuticals	AUD 93.48M		1.04M	2025-12